logo
Share

Johnson & Johnson looks to start human trials of COVID-19 vaccine in September

Johnson & Johnson has announced the selection of a lead Covid-19 vaccine candidate with an expansion of its existing partnerships between the Janssen Pharmaceutical Companies of Johnson & Johnson and the Biomedical Advanced Research and Development Authority. The company expects to start human trials of the vaccine by September this year, joining for more is Ludovic de Beaucoudrey, Medical Affairs Director at Janssen South Africa.

Mon, 04 May 2020 11:12:24 GMT

Sign Up for Our Newsletter Daily Update

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.